CJC-1295 is an analog of growth hormone-releasing hormone, but its modified with a longer half-life for sustained growth hormone release.2 Meanwhile, ipamorelin mimics ghrelin but operates selectively so that it targets only growth hormone release, having no impact on other hormones (e.g., cortisol) that similar peptides often affect.3 4 Together, they allow your body to produce more growth hormone more often, thus facilitating muscle growth and fat loss over an extended period.5 Because of their complementary time-release characteristics, theyre commonly used together
Systemic effects including cognitive benefits, mood regulation, and general tissue maintenance could work with either route, though injection delivers more predictable exposure levels
P.SmyllieN
J Multidiscip Care
The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications
Orforglipron users reported a higher incidence of nausea, vomiting, and constipation compared to placebo treatments